论文信息 - NICE’s 2008 Methods Guide - 字舞流文

NICE’s 2008 Methods Guide

[1] Mark Sculpher,et al. Subgroups and Heterogeneity in Cost-Effectiveness Analysis , 2012, PharmacoEconomics.

[2] J. Hutton,et al. Coverage with Evidence Development: An examination of conceptual and policy issues , 2007, International Journal of Technology Assessment in Health Care.

[3] A. Miners. Estimating ‘Costs’ for Cost-Effectiveness Analysis , 2012, PharmacoEconomics.

[4] L. Longworth,et al. NICE Methodology for Technology Appraisals , 2012, PharmacoEconomics.

[5] Karl Claxton,et al. Exploring Uncertainty in Cost-Effectiveness Analysis , 2012, PharmacoEconomics.

[6] Keith Abrams,et al. Use of Indirect and Mixed Treatment Comparisons for Technology Assessment , 2012, PharmacoEconomics.

[7] G. Hawthorne,et al. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments , 2001, Annals of medicine.

[8] S. Tunis,et al. Coverage options for promising technologies: Medicare's 'coverage with evidence development'. , 2006, Health affairs.

[9] John Brazier,et al. Valuing Health States for Use in Cost-Effectiveness Analysis , 2012, PharmacoEconomics.

[10] Julia Earnshaw,et al. NICE Guide to the Methods of Technology Appraisal , 2012, PharmacoEconomics.